RETRACTED: Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances α-synuclein fibril formation in vitro
Authors:
- Mitsuhiro YoshitaMYMitsuhiro Yoshita
- Masahito YamadaMYMasahito Yamada
- 1 February 2007
- journal article
- retracted article
- Published by Elsevier in Experimental Neurology
- Vol. 203 (2) , 579-583
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- RETRACTED: Cerebrospinal fluid of Alzheimer patients promotes β-amyloid fibril formation in vitroNeurobiology of Disease, 2005
- α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasmaThe FASEB Journal, 2003
- Metal-triggered Structural Transformations, Aggregation, and Fibrillation of Human α-SynucleinJournal of Biological Chemistry, 2001
- Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjectsNeuroscience Letters, 2000
- Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformationProceedings of the National Academy of Sciences, 2000
- Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)Neurology, 1996
- Identification of two distinct synucleins from human brainFEBS Letters, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Determination of proteins by using the color reaction with pyrocatechol violet-molybdenum(VI) complex.Chemical and Pharmaceutical Bulletin, 1984
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982